J.J. Abrams Series ‘Demimonde’ Not Going Forward At HBO Over Budget Issues

Nellie Andreeva
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

HBO is officially not moving forward with J.J. Abrams’ ambitious HBO sci-fi drama series Demimonde. The decision comes after weeks of discussions with Abrams, his Bad Robot production company and Warner Bros. Television which were focused on the show’s budget. As Deadline reported last month, the studios on the project, Warner Bros. Television and HBO, had been trying to rein in costs, but Bad Robot kept firm on their proposed budget, said to be in the mid-$200 million range, and would not agree to a reduction.

The final stages of the Demimonde conversations were held against the background of a larger reevaluation of the massive deal Abrams’ Bad Robot has at Warner Bros for film, TV, gaming and digital content as the new Warner Bros. Discovery is scrutinizing every aspect of the assets they took over when the merger was completed in April.

More from Deadline

Bought by HBO four years ago with a straight-to-series order, Demimonde, which was  developed and sold under Bad Robot’s previous WBTV pact, was still in early pre-production when the plug was pulled.

Written, executive produced and to be directed by Abrams, Demimonde, his first solo TV creation since Alias, was to star Danielle Deadwyler as Olive Reed who is torn away from her husband and daughter in a brutal scientific accident. She is forced to unravel a conspiracy to reunite with her family, now lost to a dark, distant other world.

Kira Snyder, Rand Ravich & Far Shariat served as showrunners. They executive produced with Bad Robot’s Abrams and Ben Stephenson. Rachel Rusch Rich was co-executive producer.

Last summer, HBO Max opted not to go forward with another Bad Robot series, The Shining offshoot series Overlook. The project has since been set up at Netflix. It is unclear whether Demimonde would be shopped to other buyers.

Best of Deadline

Sign up for Deadline's Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.

Click here to read the full article.